Skip to content

Clinical Trials

Tigerlily Foundation’s Clinical Trials Program is a transformational initiative to accelerate the delivery of innovative treatments to our patients, with a strategic focus on populations that are facing the highest disparities. 

Why do we do this work?

  • We know that most patients of color are not offered trials until their cancers are at a more advanced stage.

  • We know that people of color are underrepresented in clinical trials, yet have the highest mortality rates across multiple disease states.

  • We know that is unacceptable.

  • We are working to transform the clinical trial landscape by building trust and transparency, to achieve equity in clinical trials in this lifetime by holding stakeholders accountable and dismantling barriers for patients of color.

FACT #1

Black people account for less than 5% of participants in clinical trials.

(FDA 2019 Drug Trial Snapshot Summary Report)
Clinical-Trials-Picture-Fact-One-cropped
Clinical Trials 2nd Picture

FACT #2

Black women under 35 get breast cancer at two times the rate of white women and die at three times the rate.

(Lisa A. Carey. et al., “Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study,” Journal of the American Medical Association) 

FACT #3

Lack of diversity and representation in clinical trials are the primary reasons why it is not known which treatments are most effective treatments for Black women with breast cancer.

(Yedjou CG, Sims JN, Miele L, et al. Health and Racial Disparity in Breast Cancer. Adv Exp Med Biol. 2019;1152:31-49. doi:10.1007/978-3-030-20301-6_3)
Clinical Trials

Our Why

The Facts About Clinical Trials

Trial Match

CLEART

Content Library

No More Barriers

Upcoming Events/Activities

JULY TBD

FOCUS GROUP – Virtual

We are hosting a focus group dedicated to Black women with breast cancer who have not participated in a trial. We aren’t here to try to change your mind-you are the expert on you, and we respect that! Our goal with this group is to create a safe space for you to openly share your experiences, concerns, and any fears that impacted your decision. We will be holding space, listening, and learning from you-the expert! 

> CLICK HERE TO REGISTER

Our Partners & Supporters

(see full list)

Amgen
Daiichi-Sankyo-512
Web
Jan 2022 Merck Logo
lilly
Seagen-Approved-2022
220110-SANOFI-LOGO-RGB

Let’s connect on social!

Facebook Posts

Episode 6 of BREATHE Tv is live! In this episode we dive into the topic of The Science of Breast Cancer and integrating soul. The impact cancer goes far beyond the physical, it has a significant impact on every aspect of the individual. In this episode LaToya and Kim Survivor. share their experiences and talk about breast cancer, the science of cancer itself and the human experience. Bayer Merck Careers Sanofi Amgen Seattle Genetics, Inc, Eli Lilly and Company Daiichi Sankyo Brasil ... See MoreSee Less
View on Facebook
Join us for the latest episode of BREATHE Tv which will go beyond the Science of Breast Cancer and integrate soul into our discussion. We will discuss the emotional impact of cancer on lives and how we navigate through keeping the faith and hope. Maimah sits down with two Tigerlily ANGEL Advocates - Latoya Bolds-johnson who had a decade of experience as a medical physician's assistant and understands well the science of breast cancer. LaToya will share how she is using her expertise and experience to help others. Kimberly Wyatt has lived through the breast cancer journey with two separate diagnosis and is using her experiences to help others through advocacy. ... See MoreSee Less
View on Facebook